EDITORIAL

1. Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production
2. Emerging trends in clinical cancer genomic research
3. Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
4. Bacterial therapy: a promising strategy for cancer immunotherapy
5. Single-arm trials for domestic oncology drug approvals in China

MINI REVIEW

1. The outpost against cancer: universal cancer only markers

REVIEW

1. Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer
2. Progress in oncolytic viruses modified with nanomaterials for intravenous application
3. Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors

ORIGINAL ARTICLE

1. TNFSF15 facilitates the differentiation of CD11b+ myeloid cells into vascular pericytes in tumors